Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck's Keytruda and Gardasil outperform expectations, boosting annual revenue forecast
09:26am, Tuesday, 01'st Aug 2023
Merck & Co Inc (NYSE:MRK) saw strong sales during the second quarter for its cancer drug Keytruda and HPV vaccine Gardasil, leading the pharmaceutical company to raise its full-year guidance. Keytruda
Merck (MRK) Reports Q2 Loss, Tops Revenue Estimates
08:55am, Tuesday, 01'st Aug 2023
Merck (MRK) came out with a quarterly loss of $2.06 per share versus the Zacks Consensus Estimate of a loss of $2.17. This compares to earnings of $1.87 per share a year ago.
Merck CEO Rob Davis on Q2 results: We continue to see phenomenal growth
08:11am, Tuesday, 01'st Aug 2023
Merck chairman and CEO Rob Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which reported second-quarter revenue that topped expectations on strong sales of its blockbust
Merck posts narrower-than-expected loss and sales top estimates
06:46am, Tuesday, 01'st Aug 2023
Merck & Co. Inc. MRK, +0.29% posted a narrower-than-expected loss for the second quarter early Tuesday following its acquisition of Prometheus Bio and sales that topped estimates, despite a steep decl
Merck posts narrower-than-expected loss as sales of top drugs beat Street estimates
06:37am, Tuesday, 01'st Aug 2023
Merck & Co posted narrower-than-expected second-quarter loss and raised its full-year profit forecast on Tuesday on the strength of its two top-selling products, cancer immunotherapy Keytruda and huma
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
06:32am, Tuesday, 01'st Aug 2023
Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.
Dow Jones Today: Index Higher For Second Straight Month
05:10pm, Monday, 31'st Jul 2023
The Dow closed July with a gain of 3%, moving up 100 points, or 0.28% on the session, as investors watch earnings and prepare for Friday's job report.
3 Pharma Stocks to Buy for Their Promising Progress
05:34am, Monday, 31'st Jul 2023
Identifying promising pharma stocks is no small feat in the dynamic and competitive realm of pharmaceuticals. The industry is replete with businesses boasting robust pipelines, each vying for a breakt
7 Dow Stocks to Buy as Recession Fears Roll Back
03:24pm, Sunday, 30'th Jul 2023
With the Dow Jones soaring on fading recession fears, its holdings are also becoming far more attractive, too. In fact, here are seven of the top Dow stocks to buy immediately.
Merck's Keytruda gets encouraging study result ahead of earnings next week
12:02pm, Friday, 28'th Jul 2023
Merck & Co Inc (NYSE:MRK)'s flagship breast cancer drug Keytruda met one of the primary goals of a late-stage clinical trial in breast cancer patients, the company announced Friday. Taken in combina
Merck's Keytruda meets main goal in late-stage breast cancer study
07:28am, Friday, 28'th Jul 2023
Merck said on Friday its blockbuster drug Keytruda, in combination with chemotherapy, met one of the main goals in a late-stage trial testing it in some breast cancer patients.
Merck's 2Q results next week will reveal the state of Keytruda demand in the US
12:10pm, Thursday, 27'th Jul 2023
Merck & Co Inc (NYSE:MRK) is slated to report its second quarter earnings on August 1 before the opening bell, and analysts will be watching for another earnings beat. The pharmaceutical giant has t
Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma
06:55am, Wednesday, 26'th Jul 2023
Merck & Co. MRK, -1.16% and Moderna Inc. MRNA, -0.93% said Wednesday they have launched a Phase 3 trial of Moderna's V940 in combination with Merck's Keytruda as a treatment for patients with high-ris
Janux: Merck Deal, Loads Of Cash, Solid Early Data
11:56am, Tuesday, 25'th Jul 2023
Janux Therapeutics, Inc. is a small company with a deal from Merck & Co., Inc. and some solid early data. They are loaded with cash and have a long runway. Janux Therapeutics generates considerable sm
Merck Stock Not Likely To Be Saved By Dividends
07:02pm, Friday, 21'st Jul 2023
Merck & Co., Inc. has increased reliance on Keytruda and Gardasil. Merck became a Seeking Alpha Quant system Strong Buy on July 11 for no clear reason. Clinical catalysts have so far not moved Merck s
